Bienville Capital Management’s Pfizer PFE Stock Holding History

Bienville Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-6,709	Closed	-$208K	–	157
2020 Q2	$208K	Buy	+6,709	New	+$228K	0.02%	131
2019 Q3	–	Sell	-8,667	Closed	-$356K	–	170
2019 Q2	$356K	Buy	8,667 +123	+1%	+$4.88K	0.04%	117
2019 Q1	$344K	Sell	8,544 -213	-2%	-$8.53K	0.04%	108
2018 Q4	$363K	Buy	+8,757	New	+$364K	0.07%	96
2018 Q1	–	Sell	-8,423	Closed	-$289K	–	190
2017 Q4	$289K	Hold	8,423	–	–	0.05%	147
2017 Q3	$285K	Buy	8,423 +889	+12%	+$28.6K	0.05%	128
2017 Q2	$240K	Hold	7,534	–	–	0.07%	142
2017 Q1	$245K	Sell	7,534 -585	-7%	-$18.4K	0.06%	130
2016 Q4	$250K	Sell	8,119 -2,108	-21%	-$64.4K	0.06%	116
2016 Q3	$329K	Sell	10,227 -692	-6%	-$23.1K	0.08%	92
2016 Q2	$365K	Buy	+10,919	New	+$348K	0.1%	74

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Bienville Capital Management's PFE Position: Q3 2020 in Review

Bienville Capital Management sold out of Pfizer (PFE) in Q3 2020, closing a stake of 6,709 shares — an estimated $208K sold.

Bienville Capital Management first reported a position in PFE in Q2 2016 and held it in 11 quarters. The position peaked at $365K in Q2 2016. 2,509 funds tracked by Wall St. Rank hold PFE as of Q3 2020.

Bienville Capital Management reported no remaining Pfizer position as of Q3 2020 after selling out during the quarter.
Bienville Capital Management sold 6,709 Pfizer shares in Q3 2020, an estimated $208K.
Bienville Capital Management first reported a position in Pfizer in Q2 2016 and held it in 11 quarters.
Bienville Capital Management's Pfizer position peaked at $365K in Q2 2016.
2,509 funds tracked by Wall St. Rank held Pfizer as of Q3 2020.

Based on Bienville Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.